MUSTANG BIO, INC. Income Statement
MBIO|4 years of annual SEC 10-K data (FY2016-FY2019)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 4 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.37 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|
| Revenue | - | $50.0K | - | $0 |
| SG&A Expense | $6.8M | $11.4M | $254.0K | $254.0K |
| R&D Expense | $21.1M | $2.1M | $100.0K | $1.5M |
| Operating Income | -$31.2M | -$31.8M | -$4.3M | -$4.3M |
| Interest Expense | $8.0K | $8.0K | $0 | $0 |
| Net Income | -$30.7M | -$31.3M | -$4.5M | -$4.5M |
| EPS (Diluted) | -$1.14 | -$1.24 | -$0.45 | -$0.45 |
| Shares Outstanding | 26.6M | 25.2M | 15.2M | 2.0M |
| Operating Margin | - | -63570.0% | - | - |
| Profit Margin | - | -62576.0% | - | - |